SPINOCEREBELLAR ATAXIA 7 (SCA7) DNA DETECTION, EDTA BLOOD

image not found

NABL Cap Accredited      
The SCA7 DNA Detection test identifies abnormal CAG repeat expansions in the ATXN7 gene, the known cause of Spinocerebellar Ataxia Type 7. This inherited neurodegenerative disorder leads to progressive vision loss, coordination problems, balance issues, and muscle weakness. Metropolis Healthcare performs precise molecular analysis using EDTA blood to determine the exact repeat size for accurate diagnosis. Early detection helps guide prognosis, clinical management, and genetic counseling for affected families

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 3,275.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: S0006

Frequently Asked Questions (FAQ's):

What does the SCA7 DNA detection test look for?
It detects CAG repeat expansions in the ATXN7 gene associated with Spinocerebellar Ataxia Type 7.

How does Metropolis Healthcare conduct this test?
Metropolis Healthcare uses advanced molecular methods to analyze repeat length accurately from EDTA blood.

Who should consider undergoing this test?
Individuals with progressive visual impairment, ataxia symptoms, or a family history of SCA7.

What sample is required for the analysis?
An EDTA blood sample is needed for DNA extraction and genetic testing.

Does this test provide a confirmed diagnosis for SCA7?
Yes, identifying an expanded CAG repeat provides a definitive genetic diagnosis.

Is any preparation necessary?
No fasting or special preparation is needed.

How do the results assist in patient care?
They help guide treatment planning, monitoring, and genetic counseling for families.

Can family members be tested at Metropolis Healthcare?
Yes, Metropolis Healthcare offers targeted and predictive testing for at-risk relatives once a mutation is identified

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab